Sobi, Menarini announce Australian approval for Kineret in Juvenile Idiopathic Arthritis
Kineret has been approved for the treatment of systemic juvenile idiopathic arthritis (SJIA), which is a rare form of juvenile chronic arthritis that affects children up to 16
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.